Xenon Pharmaceuticals (XENE) Net Margin Growth (5y) (2019 - 2025)

Xenon Pharmaceuticals (XENE) Net Margin Growth (5y) (2019 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Xenon Pharmaceuticals 5.71 Bn 5.71 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2025 -76,469.00
Sep 30, 2022 -2.49 Mn
Jun 30, 2022 4.61 Mn
Mar 31, 2022 4.68 Mn
Dec 31, 2021 192,417.00
Sep 30, 2021 156,180.00
Jun 30, 2021 53,831.00
Mar 31, 2021 57,294.00
Dec 31, 2020 -11,048.00
Sep 30, 2020 -4,217.00
Jun 30, 2020 -3,014.00
Mar 31, 2020 12,573.00
Dec 31, 2019 -35,414.00
Sep 30, 2019 -27,111.00